In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer urges investors to look under the hood of Valeant Pharmaceuticals' latest earnings report.
Let's recognize that some moves are simply related to bonds, which are in the grips of a bizarre developed-world shortage.
If there really is going to be an infrastructure bill, the company should focus on consolidation.
Emphasis on 'wealth.'
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.